Stovek

Catalog Veterinary products

Enrofloxacin 20% aqua-TRV

download the instructions

Enrofloxacin 20% aqua-TRV

Description:

Enrofloxacin 20% aqua-TRV is an antibacterial veterinary product.

Dosage form: oral solution.

Composition:

1 ml contains 200 mg of enrofloxacin and excipients - potassium hydroxide, Trilon B, benzyl alcohol, highly purified water.

Indications for use:

Enrofloxacin 20% aqua-TRV is used as a therapeutic agent in cattle and small ruminants, pigs, poultry for respiratory and gastrointestinal diseases of bacterial etiology, including colibacillosis, salmonellosis, pasteurellosis, necrotizing enteritis, hemophilosis, campyloplasmosis , staphylococcosis, as well as coinfections and secondary infections in viral diseases, the causative agents of which are sensitive to enrofloxacin.

Method of administration and dosage:

The veterinary product is administered orally with drinking water individually or in groups for 3-5 days.

Calves, Lambs, Pigs

Individually 0.0125-0.025 ml of the veterinary product per 1 kg of animal weight (according to API - 2.5-5 mg per 1 kg of animal weight).

Poultry up to 4 weeks of birth

Group method 250 ml of the veterinary product per 1000 l of drinking water.

Poultry after 4 weeks of birth

Group method 500 ml of the veterinary product per 1000 l of drinking water.

The clinical signs associated with salmonellosis, the veterinary product is used in a double therapeutic dose (calves, lambs, pigs 0.025-0.05 ml / kg; poultry 500-1000 ml per 1000 l of drinking water).

Pharmaceutical properties

Enrofloxacin 20% aqua-TRV is a broad-spectrum antibacterial veterinary product providing a wide spectrum of antimicrobial and antimycoplasma activity.

Enrofloxacin - belongs to the 3rd generation fluoroquinolones, is a quinol carboxylic acid derivative, the mechanism of action is to inhibit the activity of the enzyme gyrase, which affects the replication of the DNA helix in the nucleus of a bacterial cell, leads to disruption of protein synthesis and suppression of the growth and development of gram-positive and gram-negative bacteria, including: gram-positive: aerobic cocci - Staphylococcus spp., Streptococcus spp .; anaerobic spore-forming bacteria - Clostridium spp .; gram-negative: aerobic bacteria - Escherichia coli, Haemophilus spp., Salmonella spp., Pasteurella spp., Bordetella spp., as well as Corynebacterium spp., Campylobacter spp., Pseudomonas spp., Proteus spp., Mycoplasma spp.

Enrofloxacin is well and quickly absorbed in the gastrointestinal tract and penetrates into all organs and tissues of animals, is excreted from the body mainly unchanged, mainly in urine and in small quantities with faeces, in poultry – in droppings.

The veterinary product, according to the exposure degree, belongs to low-hazard substances (hazard class 4 according to GOST 12.1.007-76).